26 results on '"Ren L"'
Search Results
2. 424P Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer: Updated survival results from the phase II PICTURE trial
3. TUMOR RESPONSE AND SECONDARY RESECTABILITY OF COLORECTAL LIVER METASTASES FOLLOWING CETUXIMAB WITH CHEMOTHERAPY: A RANDOMIZED, CONTROLLED STUDY
4. Bevacizumab plus chemotherapy versus chemotherapy alone as first-line treatment for patients with RAS mutant unresectable colorectal liver-limited metastases: A single center randomized control trial
5. Detection of 5-hydroxymethylcytosine in circulating-free DNA for early diagnosis of colorectal cancer
6. Detection of 5-hydroxymethylcytosine in circulating-free DNA for prediction of the efficacy of conversion therapy for colorectal cancer liver metastases
7. PD-L1 expression affect the efficacy of pemetrexed maintenance therapy in real-world patients with advanced non-squamous NSCLC
8. Robot-assisted procedure versus open surgery for simultaneous resection of colorectal cancer with liver metastases: Short-term outcomes of a randomized controlled study
9. Robot-assisted vs laparoscopic vs open abdominoperineal resections for low rectal cancer: Short-term outcomes of a single-center prospective randomized controlled trial
10. LBA31 - Bevacizumab plus chemotherapy versus chemotherapy alone as first-line treatment for patients with RAS mutant unresectable colorectal liver-limited metastases: A single center randomized control trial
11. 629P - Detection of 5-hydroxymethylcytosine in circulating-free DNA for prediction of the efficacy of conversion therapy for colorectal cancer liver metastases
12. 628P - Detection of 5-hydroxymethylcytosine in circulating-free DNA for early diagnosis of colorectal cancer
13. Effects of beyond KRAS mutations on the efficacy of cetuximab plus chemotherapy for patients with unresectable colorectal liver-limited metastases (BELIEF): a retrospective biomarker analysis from a Chinese trial
14. Clinical analysis of continuing crizotinib treatment beyond disease progression in ALK-positive non-small-cell lung cancer patients
15. 143O - Robot-assisted procedure versus open surgery for simultaneous resection of colorectal cancer with liver metastases: Short-term outcomes of a randomized controlled study
16. 482PD - Robot-assisted vs laparoscopic vs open abdominoperineal resections for low rectal cancer: Short-term outcomes of a single-center prospective randomized controlled trial
17. 1266P - Clinical analysis of continuing crizotinib treatment beyond disease progression in ALK-positive non-small-cell lung cancer patients
18. 541P - Effects of beyond KRAS mutations on the efficacy of cetuximab plus chemotherapy for patients with unresectable colorectal liver-limited metastases (BELIEF): a retrospective biomarker analysis from a Chinese trial
19. BRAF, PIK3CA Alterations can Predict Outcomes to Cetuximab Contained Conversion Chemotherapy in Wild-Type KRAS CLM
20. The Effect of Nadroparin and Intraportal Infusion of Tegafur on Prevent Liver Metastasis After Colorectal Cancer Surgery
21. Outcome of Patients with Colorectal Liver Metastasis: Analysis of 1613 Consecutive Cases
22. A Randomized, Controlled Trial of Cetuximab Plus Chemotherapy for Patients with Kras Wild-Type Unresectable Colorectal Liver-Limited Metastases
23. Survival Analysis of 1,061 Patients with Synchronous Colorectal Hepatic Metastases
24. O2–081BRAF, PIK3CA ALTERATIONS CAN PREDICT OUTCOMES TO CETUXIMAB CONTAINED CONVERSION CHEMOTHERAPY IN WILD-TYPE KRAS CLM.
25. 164P PD-L1 expression affect the efficacy of pemetrexed maintenance therapy in real-world patients with advanced non-squamous NSCLC.
26. O1–119THE EFFECT OF NADROPARIN AND INTRAPORTAL INFUSION OF TEGAFUR ON PREVENT LIVER METASTASIS AFTER COLORECTAL CANCER SURGERY.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.